APA

Barrow P., Richman S. D., Wallace A. J., Handley K., Hutchins G. G. A., Kerr D., Magill L., Evans D. G., Gray R., Quirke P. & Hill J. (20200120). Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. : Histopathology.

Chicago

Barrow Paul, Richman Susan D, Wallace Andrew J, Handley Kelly, Hutchins Gordon G A, Kerr David, Magill Laura, Evans D Gareth, Gray Richard, Quirke Phil and Hill James. 20200120. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. : Histopathology.

Harvard

Barrow P., Richman S. D., Wallace A. J., Handley K., Hutchins G. G. A., Kerr D., Magill L., Evans D. G., Gray R., Quirke P. and Hill J. (20200120). Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. : Histopathology.

MLA

Barrow Paul, Richman Susan D, Wallace Andrew J, Handley Kelly, Hutchins Gordon G A, Kerr David, Magill Laura, Evans D Gareth, Gray Richard, Quirke Phil and Hill James. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. : Histopathology. 20200120.